Author Archives: Henry Miller

Germline Gene Therapy: Don’t Let Good Intentions Spawn Bad Policy


This article is in Summit on Human Gene Editing, Spring 2016


The proposed moratorium on clinical applications of gene editing technology reveals ignorance about how innovation works, and callousness about human suffering. “Human gene therapy” has been one of the most ambitious goals of biotechnology since the advent of molecular techniques for genetic modification in the 1970s. There are two distinct approaches, which present different kinds […]